BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals Ltd. (BVXV) Revenue
Annual & quarterly revenue history · segment & region breakdown
BVXV · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBiondVax Pharmaceuticals Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BiondVax Pharmaceuticals Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BiondVax Pharmaceuticals Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BiondVax Pharmaceuticals Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BVXV revenue · 4 questionsBVXV's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · BiondVax Pharmaceuticals Ltd. SEC filings · GAAP · BiondVax Pharmaceuticals Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026